nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—CA9—cervical cancer	0.878	1	CbGaD
Diclofenamide—CA14—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.01	0.122	CbGpPWpGaD
Diclofenamide—CA5A—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00974	0.119	CbGpPWpGaD
Diclofenamide—CA6—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00974	0.119	CbGpPWpGaD
Diclofenamide—CA7—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00909	0.111	CbGpPWpGaD
Diclofenamide—CA5B—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00909	0.111	CbGpPWpGaD
Diclofenamide—CA12—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00842	0.103	CbGpPWpGaD
Diclofenamide—CA4—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00672	0.0819	CbGpPWpGaD
Diclofenamide—CA2—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00644	0.0785	CbGpPWpGaD
Diclofenamide—CA1—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.00617	0.0752	CbGpPWpGaD
Diclofenamide—CA6—exocrine gland—cervical cancer	0.00595	0.173	CbGeAlD
Diclofenamide—CA5A—female reproductive system—cervical cancer	0.00298	0.0868	CbGeAlD
Diclofenamide—Hydrochlorothiazide—CA9—cervical cancer	0.00266	0.529	CrCbGaD
Diclofenamide—CA7—renal system—cervical cancer	0.00248	0.0721	CbGeAlD
Diclofenamide—Trichlormethiazide—CA9—cervical cancer	0.00237	0.471	CrCbGaD
Diclofenamide—CA1—C-MYB transcription factor network—PIAS3—cervical cancer	0.00211	0.0257	CbGpPWpGaD
Diclofenamide—CA2—exocrine gland—cervical cancer	0.00205	0.0596	CbGeAlD
Diclofenamide—CA9—female reproductive system—cervical cancer	0.00174	0.0507	CbGeAlD
Diclofenamide—CA12—renal system—cervical cancer	0.00161	0.0469	CbGeAlD
Diclofenamide—CA5B—mammalian vulva—cervical cancer	0.00135	0.0393	CbGeAlD
Diclofenamide—CA12—female reproductive system—cervical cancer	0.00129	0.0375	CbGeAlD
Diclofenamide—CA1—renal system—cervical cancer	0.00128	0.0371	CbGeAlD
Diclofenamide—CA5B—female reproductive system—cervical cancer	0.00116	0.0337	CbGeAlD
Diclofenamide—CA5B—vagina—cervical cancer	0.00105	0.0304	CbGeAlD
Diclofenamide—CA1—female reproductive system—cervical cancer	0.00102	0.0297	CbGeAlD
Diclofenamide—CA4—renal system—cervical cancer	0.000997	0.029	CbGeAlD
Diclofenamide—CA2—epithelium—cervical cancer	0.000891	0.0259	CbGeAlD
Diclofenamide—CA2—decidua—cervical cancer	0.000842	0.0245	CbGeAlD
Diclofenamide—CA2—renal system—cervical cancer	0.000826	0.0241	CbGeAlD
Diclofenamide—CA4—female reproductive system—cervical cancer	0.000798	0.0232	CbGeAlD
Diclofenamide—CA2—mammalian vulva—cervical cancer	0.000773	0.0225	CbGeAlD
Diclofenamide—CA4—female gonad—cervical cancer	0.000726	0.0211	CbGeAlD
Diclofenamide—CA5B—lymph node—cervical cancer	0.000676	0.0197	CbGeAlD
Diclofenamide—CA2—female reproductive system—cervical cancer	0.000662	0.0193	CbGeAlD
Diclofenamide—CA2—female gonad—cervical cancer	0.000602	0.0175	CbGeAlD
Diclofenamide—CA1—C-MYB transcription factor network—HES1—cervical cancer	0.000601	0.00733	CbGpPWpGaD
Diclofenamide—CA2—vagina—cervical cancer	0.000599	0.0174	CbGeAlD
Diclofenamide—CA1—lymph node—cervical cancer	0.000597	0.0174	CbGeAlD
Diclofenamide—CA9—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000562	0.00684	CbGpPWpGaD
Diclofenamide—CYP2C9—female reproductive system—cervical cancer	0.00056	0.0163	CbGeAlD
Diclofenamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000512	0.00624	CbGpPWpGaD
Diclofenamide—CA4—lymph node—cervical cancer	0.000467	0.0136	CbGeAlD
Diclofenamide—CA2—lymph node—cervical cancer	0.000387	0.0113	CbGeAlD
Diclofenamide—CA1—C-MYB transcription factor network—CD4—cervical cancer	0.000339	0.00414	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—CA9—cervical cancer	0.000203	0.00248	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—CA9—cervical cancer	0.000198	0.00241	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—CA9—cervical cancer	0.000198	0.00241	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—CA9—cervical cancer	0.000185	0.00225	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—CA9—cervical cancer	0.000185	0.00225	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CA9—cervical cancer	0.000171	0.00209	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CA9—cervical cancer	0.000137	0.00166	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CA9—cervical cancer	0.000131	0.00159	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CA9—cervical cancer	0.000125	0.00153	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—MTOR—cervical cancer	0.00012	0.00146	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—STAT3—cervical cancer	9.24e-05	0.00113	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—MTHFR—cervical cancer	8.24e-05	0.001	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—MTHFR—cervical cancer	8.03e-05	0.000979	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—MTHFR—cervical cancer	8.03e-05	0.000979	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—MTHFR—cervical cancer	7.5e-05	0.000914	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—MTHFR—cervical cancer	7.5e-05	0.000914	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—TP53—cervical cancer	7.05e-05	0.00086	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—MTHFR—cervical cancer	6.95e-05	0.000847	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—MTHFR—cervical cancer	5.54e-05	0.000675	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—MTHFR—cervical cancer	5.31e-05	0.000647	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—MTHFR—cervical cancer	5.09e-05	0.000621	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—MTHFR—cervical cancer	4.48e-05	0.000546	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CA9—cervical cancer	2.82e-05	0.000343	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—MTHFR—cervical cancer	1.14e-05	0.000139	CbGpPWpGaD
